Madrigal Pharmaceuticals
MDGL
MDGL
156 hedge funds and large institutions have $1.85B invested in Madrigal Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 60 increasing their positions, 43 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.89% more ownership
Funds ownership: 53.27% → 56.15% (+2.9%)
19% less capital invested
Capital invested by funds: $2.27B → $1.85B (-$424M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
156
Holding in Top 10
3
Calls
$101M
Puts
$24.5M
Top Buyers
| 1 | +$63M | |
| 2 | +$52.2M | |
| 3 | +$20.3M | |
| 4 |
BlackRock
New York
|
+$18.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$18.4M |
Top Sellers
| 1 | -$55.8M | |
| 2 | -$26.6M | |
| 3 | -$25.8M | |
| 4 |
PC
PointState Capital
New York
|
-$23.7M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$17.4M |